Filter posts

Therapeutic Licensing and M&A Deals

Licensing deals for therapeutic candidates in 2013 dropped to the lowest volume in at least …

BIO-Europe Spring Opening Remarks

BIO’s own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring …

Putting a Ring on It: Advice on Successful Drug Development Collaborations

Drug development partnerships can look lucrative to small biotechs eager to monetize their discoveries, but, …

Biobuck M&A in Full Gear

The 2012 M&A results are in and trends are mixed. Last year was a down …